Diverse involvement of EZH2 in cancer epigenetics - Test2 - elhamkhani - TriplyDB

Diverse involvement of EZH2 in cancer epigenetics

Diverse involvement of EZH2 in cancer epigenetics

http://www.wikidata.org/entity/Q28084911

about

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney EZH2 in normal hematopoiesis and hematological malignancies Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance.Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?Epigenetics in Cancer: A Hematological Perspective MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells Epigenetic Alterations in Parathyroid Cancers Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases.Exploiting Epigenetic Alterations in Prostate Cancer.The role of long non-coding RNAs in genome formatting and expression Significance of EZH2 expression in canine mammary tumors.miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression.Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.Metastatic biomarkers in synovial sarcoma.Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells.Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma.Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.Histone H3K14 hypoacetylation and H3K27 hypermethylation along with HDAC1 up-regulation and KDM6B down-regulation are associated with active pulmonary tuberculosis disease miR302 regulates SNAI1 expression to control mesangial cell plasticity.A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis.Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.Enhancer of zeste homolog 2 blockade by RNA interference is implicated with inhibited proliferation, invasion and promoted apoptosis in endometrial carcinoma.Downregulated lncRNA HOXA11-AS Affects Trophoblast Cell Proliferation and Migration by Regulating RND3 and HOXA7 Expression in PE.High expression of EZH2 as a marker for the differential diagnosis of malignant and benign myogenic tumors Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma

P2860

Q26746038-15AD60BD-C52B-493E-8A76-4813E3A4806E Q26765422-2A1FFBAA-CCA5-4C12-839D-8E4DAF1B722C Q26771698-D593CEC7-F85D-43C9-8DD5-67DE28CFDEFF Q26779821-512AB89B-274A-4C73-A238-E64C46FE2B36 Q27319398-A69FC8A2-1A77-4525-9C0A-D420C03A4939 Q28076548-6D573D9A-2B21-434C-869C-579DFFF18B4F Q28077082-BAE55D64-69FF-4748-A5B5-381E3E18C9EC Q28551027-84D44AF1-F1B1-4D8B-AB24-AA53957EA478 Q30398206-04E29A54-020F-40BF-B8A0-AB214EC0B6BD Q33568125-62D5FDC7-8898-4408-B5BD-0F0433426D68 Q33640720-08294E6D-DE16-4B20-9D3D-8D3D1CB8B79A Q33755160-6EC37E61-EF70-49FE-97CF-2D2D7B0CF010 Q35550745-21CC2ACC-76B4-471D-B113-78C395D8EEC3 Q36098022-8EEC85A5-C955-496A-B42B-3313793BE41D Q36782656-1B27EFD3-8BC6-4173-ABF2-FA8AD4C433E1 Q36850467-CCBA5F14-E042-42D7-91B3-E662460CAB5F Q36998179-5AF15895-C875-4B04-80EF-ACD52C2955AE Q36998353-45AA08B1-2A7A-4A13-B4F0-D4889CB0C6AD Q37030313-C1E1B0E1-C4E9-45A2-ACDD-04A6A8E5C214 Q37630943-53A56464-D10C-4C8D-884D-EA92795A3709 Q37648073-E28D1653-B07A-4F9E-A38E-D12B2632E7CB Q37708968-BBE376CD-389A-4485-B2D1-9A8E0055CB7C Q37709478-70F40D39-EA2A-4B42-967A-5522CB4A095A Q38722204-4C25C59E-C07B-48DF-BA65-A14E8414CA72 Q38993869-63A4B5FD-9487-4A23-8DD7-4D0320B252EE Q39214234-FC2399B4-93BD-4971-9D48-B9053E49A29E Q39870818-A2DCAA4E-7C6A-4E04-98C7-0E9E6E9071FB Q42068184-DDE08293-EA5B-4E46-91AA-247482904520 Q42321676-FDA4A8D3-78DA-4D0F-8E31-6123D54F2A99 Q45864008-DB1F8ABE-0E8B-424B-8262-F131B75C0576 Q47094209-B05B9595-14C3-4817-AB90-1CFA0314AF96 Q53273169-26E0E89D-8907-4205-8B40-6F822FB5D62C Q55131833-72ECC6CF-59BF-4075-8CA9-D5FBD555A0D4 Q55231527-23CB65D0-BFAC-40FF-8C89-64CE11DA5ADB Q55241876-D7360148-1A0C-405E-9884-1EC6BCF19A59 Q55380707-05C9ED1F-8FD3-4F17-8689-8DD59923DF68 Q58771183-D2DD10A8-8195-4E2F-95B7-486E59CF40D9 Q58784189-26A1AA6A-C866-4C0D-98C9-A2074A228088

P2860

Diverse involvement of EZH2 in cancer epigenetics

http://www.wikidata.org/entity/Q28084911

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Diverse involvement of EZH2 in cancer epigenetics

@ast

Diverse involvement of EZH2 in cancer epigenetics

@en

Diverse involvement of EZH2 in cancer epigenetics

@nl

type

label

Diverse involvement of EZH2 in cancer epigenetics

@ast

Diverse involvement of EZH2 in cancer epigenetics

@en

Diverse involvement of EZH2 in cancer epigenetics

@nl

prefLabel

Diverse involvement of EZH2 in cancer epigenetics

@ast

Diverse involvement of EZH2 in cancer epigenetics

@en

Diverse involvement of EZH2 in cancer epigenetics

@nl

P1433

Q28084911-2E90C622-E495-44FD-89D3-41FF36C5076C

P1476

Q28084911-24C1C168-52E3-4E7C-8EE7-694C9A5D7074

P2093

Q28084911-82A67A92-A6B9-4A99-8484-2FDC0D7CEBCC

Q28084911-A64917C5-3274-43F4-B535-84D87B922E18

Q28084911-CF9D36C4-3E64-4CB8-A847-E46159C02D11

P2860

Q28084911-0058A6DE-6CEB-4A4D-8097-50CAEA5164F7

Q28084911-0068964A-E4F8-4132-BFDA-7720CAB4919D

Q28084911-05E087FF-9CC1-42A2-AF64-48D80E37B039

Q28084911-06402270-AA7B-4FF9-ABD3-697ACEE06653

Q28084911-081F7931-7ED7-446F-BFEA-050538EAA2C1

Q28084911-0B21F4B4-E44F-4642-BA87-60AE4470226E

Q28084911-1129D341-67AF-440C-87FD-CF340CE92A61

Q28084911-1588ADB1-5718-4F43-88D5-3344CC8ED79D

Q28084911-1A9DA6BD-EEEC-4FE6-8099-AFA6A1FAC41E

Q28084911-1ADB6751-CE88-4BCF-82C6-EC0A85F047C5

P304

Q28084911-03A14445-8D02-4B9F-B423-D375F891DCCA

P31

Q28084911-D1B1FA55-F41A-4A65-B6F8-589213299DF7

P3181

Q28084911-AB00C316-81D6-4DBA-B7A4-5C2C96AE8B4E

P407

Q28084911-29AB5362-7F7A-4ABF-AD9D-5D05CE4A990D

P433

Q28084911-E48BE97A-389F-434D-A63E-E0B09E80F20D

P478

Q28084911-9E1C3752-2B9C-45A9-BBF8-DE86236F50E8

P50

Q28084911-9D875D57-DC82-4529-8A64-E7AE1487B842

P577

Q28084911-6D12ED5B-2EE2-45D9-83CC-89B0FD7AEFD6

P698

Q28084911-E3F271DE-C86A-4642-988B-AEE8E32C8C0C

P932

Q28084911-964AA938-600F-40D8-82CA-6C11F13A400D

P3181

P1433

American Journal of Translational Research

P1476

Diverse involvement of EZH2 in cancer epigenetics

@en

P2093

Barbara Dupret

http://www.w3.org/2001/XMLSchema#string

Pamela Völkel

http://www.w3.org/2001/XMLSchema#string

Xuefen Le Bourhis

http://www.w3.org/2001/XMLSchema#string

P2860

ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer

Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains

Structure and catalytic mechanism of the human histone methyltransferase SET7/9

Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2

Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity

Role of histone H2A ubiquitination in Polycomb silencing

O-GlcNAcylation regulates EZH2 protein stability and function

Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

P304

175-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1402852

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Olivier Angrand

P577

2015-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25901190

http://www.w3.org/2001/XMLSchema#string

P932

4399085

http://www.w3.org/2001/XMLSchema#string